Abstract
Infancy is a time of rapid brain development supporting foundational sensory learning. The gut microbiome, also undergoing extensive developmental changes in early life, may influence brain development through metabolism of neuroactive compounds. Here, we show across the first 18 months of life that microbial genes encoding enzymes that produce and degrade neuroactive compounds, including neurotransmitters GABA and glutamate, the amino acid tryptophan, and short-chain fatty acids including acetate and butyrate, are associated with visual neurodevelopmental learning, measured by the visual-evoked potential (VEP). Microbial gene sets from stool collected around 4 months of age were strongly associated with VEP features measured from 9 to 14 months of age and showed more associations than concurrently measured gene sets, suggesting microbial metabolism in early life may have long term effects on neural plasticity and development.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study was funded by Wellcome LEAP 1kD
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Health Research Ethics Committees (University of Cape Town study number: 666/2021)
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
All data produced in the present study are available upon reasonable request to the authors. Upon publication in a peer reviewed journal, data and code will be archived at Dryad and Zenodo respectively